It’s been an exciting several months at Synaptive Medical. The trend began with the formation of a strategic partnership between Synaptive and General Atlantic in October of 2016. Among other things, General Atlantic saw the potential in the company’s BrightMatter suite of advanced visual and information tools for surgeons.
“Synaptive marks the first investment by General Atlantic in the medical device sector, which speaks volumes to the attractive market opportunity we see in the healthcare technology industry,” said Alex Crisses, Managing Director at General Atlantic.
As part of the partnership, Crisses and General Atlantic Principal David Caluori joined Synaptive’s board of directors.
Synaptive took another step forward in March of 2017, when four well-known medical technology experts joined its board.
Peter Wehrly was appointed Chairman of the board of directors. Richard Butland, Glenn D. Steele Jr. (MD, Ph.D), and Michael F. DeMane have also joined Synaptive’s board.
“These appointments bring an abundance of business and medical acumen to Synaptive Medical,” said Cameron Piron, president, co-founder, and outgoing executive chairman of the board of directors. “Peter, Michael, and Richard have extensive experience in leading medical technology companies and a deep understanding of the medical device sector, while Dr. Steele is the first medical doctor to join our board and brings a wealth of perspective navigating the intersection of healthcare and business.”
Peter Wehrly is the president and CEO of medical technology company PQ Bypass. He is the former group president of developed markets at Covidien, a manufacturer of medical devices. Prior to that position, he served as Covidien’s President of Respiratory and Monitoring Solutions and was responsible for Covidien’s Japanese, Australia-New Zealand, and Canadian businesses.
Dr. Glenn D. Steele, Jr. currently serves as the chairman of xG Health Solutions, an independently operated venture launched by Geisinger Health System to help healthcare organizations create value and improve quality. He also serves as vice chair of Health Transformation Alliance (HTA), a group of corporations whose goal is to improve the way corporations provide benefits in order to create better health care outcomes for their employees. Among other honors, Dr. Steele has served as Richard T. Crane Professor in the University of Chicago’s Department of Surgery and the William V. McDermott Professor of Surgery at Harvard Medical School.
Michael DeMane was CEO of Nevro Corp, a medical device company that specializes in helping patients with chronic pain, from 2011 to 2016. He became the Chairman of the Nevro board in January 2017. He is a board member for medical technology startups Cardionomic and Rotation Medical and also served as independent director of eResearch Technology Inc., a public company specializing in contract research clinical services.
Richard Butland is the managing partner of Kite Capital, a growth-oriented private investment firm. Prior to establishing Kite Capital, he spent 15 years at Goldman Sachs, where he served in the UK Advisory Group and was named managing director. He also ran the UK M&A advisory business in 2007 and subsequently moved to the merchant banking division to head its private equity activities in the UK and natural resources across Europe.
Synaptive Medical, Inc., a Toronto-based medical device and technology company, collaborates with leading clinicians and healthcare systems to devise products and services whose goal is to enable continuous improvement in care delivery in and beyond the operating room.